An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: 1. The roles of minor H antigens and endotoxin

Blood

Volumn 88, Issue 8, 1996, Pages 3230-3239

  Cooke, Kenneth R ^a   Kobzik, Lester ^b   Martin, Thomas R ^b   Brewer, Joanne ^b   Delmonte Jr , John ^b   Crawford, James M ^b   Ferrara, James L M ^b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; ENDOTOXIN; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BIOPSY; BONE MARROW TRANSPLANTATION; EXPERIMENTAL MODEL; GRAFT VERSUS HOST REACTION; HYPOXEMIA; LUNG INJURY; LUNG LAVAGE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL;

EID: 0029909099     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.8.3230.bloodjournal8883230     Document Type: Article

References (55)

1. Clark J, Hansen J, Hertz M, Parkman R, Jensen L, Peavy H: Idiopathic pneumonia syndrome after bone marrow transplantation. Am Rev Respir Dis 147:1601, 1993
2. Crawford S, Hackman R: Clinical course of idiopathic pnemonia after bone marrow transplantation. Am Rev Respir Dis 147:1393, 1993
3. Weiner RS, Mortimer MB, Gale RP, Gluckman E, Kay HEM, Kolb JJ, Hartz AJ, Rimm AA: Interstitial pneumonitis after bone marrow transplantation. Ann Intern Med 104:168, 1986
4. Quabeck K: The lung as a critical organ in marrow transplantation. Bone Marrow Transplant 14:S19, 1994
5. Crawford SC, Hackman RC: Clinical presentation, pathology and outcome of idiopathic pneumonia after marrow transplantation. Am Rev Respir Dis 141:A48, 1990 (abstr)
6. Perreault C, Cousineau S, Giovanni D, Gyger M, Nepveu F, Bioleau J, Bonny Y, Lacombe M, Lavallee R: Lymphoid interstitial pneumonia after allogeneic bone marrow transplant. Cancer 55:1, 1985
7. Sloane J, Depledge M, Rowles R, Morgenstern G, Trickey B, Dady P: Histopathology of the lung after bone marrow transplantation. J Clin Pathol 36:546, 1983
8. Neiman P, Wasserman PB, Wentworth BB, Kao G, Lemer KG, Storb R, Buckner CD, Clift RA, Fefer L, Glucksberg H, Thomas ED: Interstitial pneumonia and cytomegalovirus infection as complications of human marrow transplantation. Transplantation 15:478, 1973
9. Crawford S, Longton G, Storb R: Acute graft versus host disease and the risks for idiopathic pneumonia after marrow transplantation for severe aplastic anemia. Bone Marrow Transplant 12:225, 1993
10. Beschorner W, Saral R, Hutchins G, Tutschka P, Santos G: Lymphocytic bronchitis associated with graft versus host disease in recipients of bone marrow transplants. N Engl J Med 299:1030, 1978
11. Bortin M, Ringden O, Horowitz M, Rozman C, Weiner R, Rimm A: Temporal relationships between the major complications of bone marrow transplantation for leukemia. Bone Marrow Transplant 4:339, 1989
12. Appelbaum FR, Meyers JD, Fefer A, Flournoy N, Cheever MA, Greenberg PD, Hackman R, Thomas ED: Nonbacterial nonfungal pneumonia following marrow transplantation in 100 identical twins. Transplantation 33:265, 1982
13. Pecego R, Hill R, Appelbaum FR, Amos D, Buckner CD, Fefer A, Thomas ED: Interstitial pneumonitis following autologous bone marrow transplantation. Transplantation 42:515, 1986
14. Connor R, Ramsay N, McGlave P, Snover D, Kersey J, Burke B: Pulmonary pathology in bone marrow transplant recipients. Lab Invest 46:3, 1982
15. Korngold R, Sprent J: Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T-cells from marrow. J Exp Med 148:1687, 1978
16. Blatter DD, Crawford JM, Ferrara JLM: Nuclear magnetic resonance of hepatic graft-versus-host disease in mice. Transplantation 50:1011, 1990
17. Down JD, Mauch P, Warhol M, Neben S, Ferrara JLM: The effect of donor T lymphocytes and total-body irradiation on hemopoietic engraftment and pulmonary toxicity following experimental allogeneic bone marrow transplantation. Transplantation 54:802, 1992
18. Abhyankar S, Gilliland DG, Ferrara JLM: Interleukin 1 is a critical effector molecule during cytokine dysregulation in graftversus-host disease to minor histocompatibility antigens. Transplantation 53:1518, 1993
19. Blazar BR, Taylor PA, Snover DC, Sehgal SN, Vallera DA: Murine recipients of fully mismatched donor marrow are protected from lethal graft-versus-host disease by the in vivo administration of rapamycin but develop an autoimmune-like syndrome. J Immunol 151:5726, 1993
20. Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Gray G, Vallera DA: Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts. Blood 85:2607, 1995
21. Fontaine P, Perreault C: Diagnosis of graft-versus-host disease in mice transplanted across minor histocompatibility barriers. Transplantation 49:1177, 1990
22. Unkeless JC: Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med 150:580, 1979
23. Shulman HM, Sharma P, Amos D, Fenster LF, McDonald GB: A coded histologic study of hepatic graft-versus-host disease after human bone marrow transplantation. Hepatology 8:463, 1988
24. Brigham KL, Meyrick B: Endotoxin and lung injury. Am Rev Respir Dis 133:913, 1986
25. Strieter RM: Endothelial cell gene expression of a neutrophil chemotactic factor by TNFα, LPS and IL-β. Science 243:1467, 1989
26. Nestel FP, Price KS, Seemayer TA, Lapp WS: Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease. J Exp Med 175:405, 1992
27. Krenger W, Snyder KM, Byon CH, Falzarano G, Ferrara JLM: Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease. J Immunol 155:585, 1995
28. Lambert SB, Frazier-Jessen MR, VanStedum S, Hahn EL, Filkins JP, Garrity ER Jr, Kovacs EJ: Bronchoalveolar lavage fluid endotoxin elevation in human single lung transplant recipients during rejection. Transplant Immunol 3:81, 1995
29. Holler E, Kolb HJ, Hintermeier-Knabe R, Mittermuller J, Thierfelde S, Kaul M, Wilmanns W: The role of tumor necrosis factor alpha in acute graft-versus-host disease and complications following allogeneic bone marrow transplantation. Transplant Proc 25:1234, 1993
30. Holler E, Kolb HJ, Mittermuller J, Kaul M, Ledderose G, Duell T, Seeber B, Schleuning M, Hintermeier-Knabe R, Ertl B, Kempeni J, Wilmanns W: Modulation of acute graft-versus-host disease after allogeneic bone marrow transplantation by tumor necrosis factor a (TNFα) release in the course of pretransplant conditioning: Role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNFα (MAK 195F). Blood 86:890, 1995
31. Piguet PF, Grau GE, Allet B, Vassalli PJ: Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-versus-host disease. J Exp Med 166:1280, 1987
32. Piguet PF: Tumor necrosis factor and graft-versus-host disease, in Burakoff SJ, Deeg HJ, Ferrara JLM, Atkinson K (eds): Graft-vs.-Host Disease. New York, NY, Marcel Dekker, 1990, p 258
33. Kunkel SL, Stricter RM: Cytokine networking in lung inflammation. Hosp Prac 25:63, 1990
34. Kelley J: Cytokines of the lung. Am Rev Respir Dis 141:765, 1990
35. Bachwich PR, Lynch JP III, Larrick J, Spengler M, Kunkel SL: Tumor necrosis factor production by human sarcoid alveolar macrophages. Am J Pathol 125:421, 1986
36. Piguet P, Collart M, Grau G, Sappino A, Vassalli P: Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis. Nature 344:245, 1990
37. Holler E, Kolb HJ, Moller A, Kempeni J, Lisenfeld S, Pechumer H, Lehmacher W, Ruckdeschel G, Gleixner B, Riedner C. Ledderose G, Brehm G, Mittermuller J, Wilmanns W: Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. Blood 75:1011, 1990
38. Matuschak GM, Rinaldo JE: Organ interactions in the adult respiratory distress syndrome during sepsis. The role of the liver in host defense. Chest 94:400, 1988
39. Matuschak GM: Liver-lung interactions in critical illness. New Horizons 2:488, 1994
40. Workman D, Clancy JJ: Interstitial pneumonitis and lymphocytic bronchiolitis/bronchitis as a direct result of acute lethal graft-versus host disease duplicate the histopathology of lung allograft rejection. Transplantation 58:207, 1994
41. Piguet PF, Grau GE, Collart MA, Vassalli P, Kapanci Y: Pneumopathies of the graft-versus-host reaction. Alveolitis associated with an increased level of tumor necrosis factor mRNA and chronic interstitial pneumonitis. Lab Invest 61:37, 1989
42. Stein-Streilein J, Lipscomb MF, Hart DA, Darden A: Graft-versus-host reaction in the lung. Transplantation 32:38, 1981
43. Antin J, Ferrara J: Cytokine dysregulation and acute graft-versus-host disease. Blood 80:2964, 1992
44. Schmidt J, Pliver CN, Lepe-Zuniga JL, Green I, Gery I: Silica-stimulated monocytes release fibroblast proliferation factors identical to interleukin-1. A potential role for interleukin-1 in the pathogenesis of silicosis. J Clin Invest 73:1462, 1984
45. Suter P, Suter S, Girardin E, Roux-Lombard P, Grau G, Dayer J: High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock or sepsis. Am Rev Resp Dis 145:1016, 1992
46. Hyers T, Tricomi S, Dettenmier P, Fowler A: Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis 144:268, 1991
47. Lilly C, Sandhu J, Ishizaka A, Harada H, Yonemaru M, Larrick J. Shi T, O'Hanley T, Raffin T: Pentoxifylline prevents tumor necrosis factor-induced lung injury. Am Rev Respir Dis 139:1361, 1989
48. Eisser G, Kohluber F, Grell M, Ueffing M, Scheurich P, Hieke A, Multhoff G, Bornkamm GW, Holler E: Critical involvement of transmembrane tumor necrosis factor a in endothelial programmed cell death mediated by ionizing radiation and bacterial endotoxin. Blood 86:4184, 1995
49. Wojno K, Vogelsang G, Beschorner W, Santos G: Pulmonary hemorrhage as a cause of death in allogeneic bone marrow recipients with severe acute graft-versus host disease. Transplantation 57:88, 1994
50. Robbins RA, Linder J, Stahl MG, Thompson AB III. Haire W, Kessinger A, Armitage JO, Arneson M, Woods G. Vaughan WP, Rennard SI: Diffuse alveolar hemorrhage in autologous hone marrow transplant recipients. Am J Med 87:511, 1989
51. Chao NJ, Duncan SR, Long GD, Horning SJ, Blume KG: Corticosteroid therapy for diffuse alveolar hemorrhage in autologous bone marrow transplant recipients. Ann Intern Med 114:145, 1991
52. Katz M, Grosfeld J, Gross K: Impaired bacterial clearance and trapping in obstructive jaundice. Am J Surg 199:14, 1984
53. Matuschak G, Mattingly M, Tredway T, Lechner A: Liver-lung interactions during E. coli endotoxemia. TNF-α:leukotriene axis. Am J Respir Crit Care Med 149:41, 1994
54. Nakao A, Taki S, Yasui M, Kimura Y, Nonami T, Harada A, Takagi H: The fate of intravenously injected endotoxin in normal rats and in rats with liver failure. Hepatology 19:1251, 1994
55. Pugin J, Chevrolet JC: The intestine-liver-lung axis in septic syndrome. J Suisse Med 121:1538, 1991